All Stories

  1. Isothermal Detection of Influenza D using RT-LAMP
  2. Report from the 2025 research showcase and open discussion on equine vector‐borne diseases in the UK
  3. Mitochondrial DNA sequencing of horse breeds found in north-west Nigeria
  4. Effectiveness of a screening protocol employed at a UK rescue centre to prevent introduction of strangles
  5. Report from the 2025 research showcase & open discussion on equine vector-borne diseases in the UK
  6. Development and optimisation of Influenza C and Influenza D pseudotyped viruses
  7. Understanding the Molecular Interactions Between Influenza A Virus and Streptococcus Proteins in Co-Infection: A Scoping Review
  8. Should the equine community be concerned about the emergence of the H5N1 subtype of highly pathogenic avian influenza in US cattle?
  9. The Value of a Comparative Approach with Equine Vaccine Development for the Development of Human Influenza DNA Vaccines
  10. Role of pseudotyped viruses in understanding epidemiology, pathogenesis and immunity of viral diseases affecting both horses and humans
  11. Modelling the Influence of Climate and Vector Control Interventions on Arbovirus Transmission
  12. A systematic review quantifying host feeding patterns ofCulicoidesspecies responsible for pathogen transmission
  13. The Potential of Plant-Produced Virus-like Particle Vaccines for African Horse Sickness and Other Equine Orbiviruses
  14. Knowns and unknowns of TiLV-associated neuronal disease
  15. Development of Virus-like Particle Plant-Based Vaccines against Avian H5 and H9 Influenza A Viruses
  16. Systematic Review of Equine Influenza A Virus Vaccine Studies and Meta-Analysis of Vaccine Efficacy
  17. Advances in the understanding, detection and management of equine strangles
  18. Tilapia Lake Virus Vaccine Development: A Review on the Recent Advances
  19. Therapeutic Phage Display-Derived Single-Domain Antibodies for Pandemic Preparedness
  20. The persistence of equine strangles
  21. Seroprevalence of Equine Influenza and Its Associated Risk Factors in Northwest Nigeria
  22. An Equine Model for Vaccination against a Hepacivirus: Insights into Host Responses to E2 Recombinant Protein Vaccination and Subsequent Equine Hepacivirus Inoculation
  23. Inference for a spatio-temporal model with partial spatial data: African horse sickness virus in Morocco
  24. Gene Expression Profile Induced by Two Different Variants of Street Rabies Virus in Mice
  25. Development of Plant-Based Vaccines for Prevention of Avian Influenza and Newcastle Disease in Poultry
  26. Re‐parameterization of a mathematical model of African horse sickness virus using data from a systematic literature search
  27. Serological Cross-Reactions between Expressed VP2 Proteins from Different Bluetongue Virus Serotypes
  28. A Scoping Review of West Nile Virus Seroprevalence Studies among African Equids
  29. Perceptions and Experiences of the University of Nottingham Pilot SARS-CoV-2 Asymptomatic Testing Service: A Mixed-Methods Study
  30. Retrospective serological survey for influenza in horses from Brazil
  31. Systematic review and meta‐analysis of seroprevalence studies of West Nile virus in equids in Europe between 2001 and 2018
  32. Evaluation of a Pseudotyped Virus Neutralisation Test for the Measurement of Equine Influenza Virus-Neutralising Antibody Responses Induced by Vaccination and Infection
  33. Serosurvey of pandemic H1N1 influenza A virus in dogs in Andalusia (southern Spain)
  34. Equine viral encephalitis: prevalence, impact, and management strategies
  35. Bluetongue virus outer-capsid protein VP2 expressed in Nicotiana benthamiana raises neutralising antibodies and a protective immune response in IFNAR −/− mice
  36. The challenges posed by equine arboviruses
  37. Strategic implementation of vaccines for control of equine influenza
  38. The Optimisation of Pseudotyped Viruses for the Characterisation of Immune Responses to Equine Influenza Virus
  39. The Influenza NS1 Protein: What Do We Know in Equine Influenza Virus Pathogenesis?
  40. Canine parvovirus study
  41. Making sense of altmetrics
  42. Controlling equine influenza: Traditional to next generation serological assays
  43. Small animal disease surveillance: respiratory disease
  44. Modulation of Potassium Channels Inhibits Bunyavirus Infection
  45. Technical considerations for the generation of novel pseudotyped viruses
  46. Diversity of group A rotavirus on a UK pig farm
  47. Seroprevalence of Schmallenberg virus in the United Kingdom and the Republic of Ireland: 2011–2013
  48. In memoriam – Richard M. Elliott (1954–2015)
  49. Comparison of Schmallenberg virus antibody levels detected in milk and serum from individual cows
  50. Identification of morphological differences between avian influenza A viruses grown in chicken and duck cells
  51. High Basal Expression of Interferon-Stimulated Genes in Human Bronchial Epithelial (BEAS-2B) Cells Contributes to Influenza A Virus Resistance
  52. Development of a surveillance scheme for equine influenza in the UK and characterisation of viruses isolated in Europe, Dubai and the USA from 2010–2012
  53. Pseudotypes: your flexible friends
  54. Potential of a sequence-based antigenic distance measure to indicate equine influenza vaccine strain efficacy
  55. The genetics of virus particle shape in equine influenza A virus
  56. Wildlife Vectors of Schmallenberg?
  57. What can mathematical models bring to the control of equine influenza?
  58. Current progress with serological assays for exotic emerging/re-emerging viruses
  59. SBV transmission
  60. Evolution of Equine Influenza Virus in Vaccinated Horses
  61. Testing for Schmallenberg Virus
  62. Schmallenberg virus
  63. Neuraminidase inhibitors for treatment of equine influenza – when all else fails?
  64. Recombination and positive selection identified in complete genome sequences of Japanese encephalitis virus
  65. herpesviruses in Egyptian rodents
  66. Antigenic and Genetic Evolution of Equine Influenza A (H3N8) Virus from 1968 to 2007
  67. Equine influenza: A review of an unpredictable virus
  68. Evaluation of two commercially available ELISAs for the diagnosis of Japanese encephalitis applied to field samples
  69. Intra- and Interhost Evolutionary Dynamics of Equine Influenza Virus
  70. Dynamics of Influenza Virus Infection and Pathology
  71. Quantifying the Impact of Immune Escape on Transmission Dynamics of Influenza
  72. Antigenic and genetic variations in European and North American equine influenza virus strains (H3N8) isolated from 2006 to 2007
  73. Control of equine influenza: scenario testing using a realistic metapopulation model of spread
  74. Vaccine failure caused an outbreak of equine influenza in Croatia
  75. Transmission of Equine Influenza Virus to English Foxhounds
  76. Protection, systemic IFNγ, and antibody responses induced by an ISCOM-based vaccine against a recent equine influenza virus in its natural host
  77. Risk factors for influenza infection in vaccinated racehorses: Lessons from an outbreak in Newmarket, UK in 2003
  78. New assays to measure equine influenza virus-specific Type 1 immunity in horses
  79. Equine influenza vaccine containing older H3N8 strains offers protection against A/eq/South Africa/4/03 (H3N8) strain in a short‐term vaccine efficacy study
  80. Frequency and phenotype of EHV-1 specific, IFN-γ synthesising lymphocytes in ponies: The effects of age, pregnancy and infection
  81. Antibody and IFN-γ responses induced by a recombinant canarypox vaccine and challenge infection with equine influenza virus
  82. Mutations conferring zanamivir resistance in human influenza virus N2 neuraminidases compromise virus fitness and are not stably maintained in vitro
  83. Vaccination against equine influenza: Quid novi?
  84. Characterisation of CTL and IFN-γ synthesis in ponies following vaccination with a NYVAC-based construct coding for EHV-1 immediate early gene, followed by challenge infection
  85. Investigation of Equine Influenza Cases Exhibiting Neurological Disease: Coincidence or Association?
  86. Evaluation of the Binax NOW Flu A test kit for the rapid detection of equine influenza virus
  87. Description of the outbreak of equine influenza (H3N8) in the United Kingdom in 2003, during which recently vaccinated horses in Newmarket developed respiratory disease
  88. Equine influenza in dogs: Too late to bolt the stable door?
  89. The use of a systemic prime/mucosal boost strategy with an equine influenza ISCOM vaccine to induce protective immunity in horses
  90. Inhaled Zanamivir Versus Rimantadine for the Control of Influenza in a Highly Vaccinated Long-term Care Population
  91. Equine interferon gamma synthesis in lymphocytes after in vivo infection and in vitro stimulation with EHV-1
  92. Characterisation of three equine influenza A H3N8 viruses from Germany (2000 and 2002): Evidence for frozen evolution
  93. Immune responses and protective efficacy in ponies immunised with an equine influenza ISCOM vaccine containing an ‘American lineage’ H3N8 virus
  94. Evidence supporting the inclusion of strains from each of the two co-circulating lineages of H3N8 equine influenza virus in vaccines
  95. The effects of strain heterology on the epidemiology of equine influenza in a vaccinated population
  96. Current perspectives on control of equine influenza
  97. Unifying the Epidemiological and Evolutionary Dynamics of Pathogens
  98. Comparison of hamster and pony challenge models for evaluation of effect of antigenic drift on cross protection afforded by equine influenza vaccines
  99. Optimising vaccination strategies in equine influenza
  100. Diagnostic methods applied to analysis of an outbreak of equine influenza in a riding school in which vaccine failure occurred
  101. Influenza HA DNA induces Th1 cells and protection despite limited antibody responses
  102. Methods for determining resistance to neuraminidase inhibitors
  103. Viral Infections of the Equine Respiratory Tract
  104. Correspondence
  105. Antigenic and genetic evolution of equine H3N8 influenza A viruses
  106. Genetic and Antigenic Analysis of the Influenza Virus Responsible for the 1992 Hong Kong Equine Influenza Epizootic
  107. Genetic and antigenic analysis of an equine influenza H 3 isolate from the 1989 epidemic